Le Lézard
Classified in: Health
Subjects: CFG, ESG

Canada takes action by endorsing global declaration on Undetectable = Untransmittable (U=U)


U=U accelerates progress towards national and global goals to end the HIV epidemic

MONTREAL, July 28, 2022 /CNW Telbec/ - Public Health Agency of Canada

Thanks to the advances in HIV science over the last four decades, people living with HIV who are on medication and maintain an undetectable amount of virus in their blood can lead a long, healthy life without the fear of passing HIV to their sexual partner. This is the powerful message behind "Undetectable = Untransmittable (U=U)"

Today, the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced Canada's endorsement for a global declaration on Undetectable = Untransmittable (U=U). This builds on Canada's leadership as the first country to formally endorse the U=U campaign in 2018.

The U=U message is linked to factors known to impact quality of life and health outcomes, including decreased stigma, improved self-image, better mental health, and greater comfort sharing status with partners, making it a key tool for combatting HIV-related stigma.

People living with HIV who are informed about U=U are more likely to report optimal mental, physical and sexual health. Knowledge of U=U increases uptake in HIV testing, treatment and achieving viral suppression, all of which supports the global goal of ending HIV and AIDS as a public health concern by 2030. This life-changing science has transformed what it means to live and love with HIV across the globe.

To-date, more than 1,000 official U=U partners from all sectors in 105 countries have signed on to the campaign to share the message. The global declaration on U=U endorsed today takes the global commitment to U=U one step further by recognizing the value of the message as a tool to advance efforts to end HIV as a public health concern, and by committing countries to integrate U=U into their policies and programs. Canada endorses the U=U campaign and the global declaration on U=U, and encourages other countries to do the same.

Quotes

"Helping people living with HIV have a healthy and stigma-free life is exactly what Canada's endorsement of U=U is all about. Today, we are reiterating our commitment to build U=U into our policies and programs to help prevent new infections and ensure that individuals living with HIV and AIDS receive the ongoing care, treatment, and support they need."

The Honourable Jean-Yves Duclos
Minister of Health

"Canada's endorsement of the U=U campaign will be vital in confronting the stigma and discrimination that has impacted the HIV community. Making U=U a core component of our policies and programs helps us better address systemic inequities and decrease barriers to care so that those affected by HIV have the support they need to live a healthy life. "

The Honourable Carolyn Bennett
Minister of Mental Health and Addictions, and Associate Minister of Health

Quick Facts

Associated Links

U=U testimonials of people living with HIV in Canada

HIV factsheet: U=U for health professionals

HIV in Canada - People living with HIV and new HIV infections, 2020 

Canada's progress towards global HIV targets (90-90-90), 2020 

Reducing the health impact of sexually transmitted and blood-borne infections in Canada by 2030: A pan-Canadian STBBI framework for action

Accelerating our response: Government of Canada five-year action plan on sexually transmitted and blood-borne infections

2019-2020 Progress report for the Government of Canada Five-Year Action Plan on Sexually Transmitted and Blood-Borne Infections 

Canada Pavilion at AIDS 2022

AIDS 2022, the 24th International AIDS Conference

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 19:10
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for COVID-19, has been accepted by China...

at 19:05
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, is furthering pre-clinical development of its proprietary doggybone DNA vaccine platform, financed by a new grant received from the...

at 18:46
DURECT Corporation , a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT's board of directors today determined that the Company will...

at 18:45
ALZpath, Inc. announced today the launch of its first diagnostic assay for detection of phosphorylated tau 217...

at 18:30
Neurelis, Inc., a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and orphan neurologic disorders characterized by high unmet medical need, today announced that...

at 18:13
OneWell, a nationwide home health services provider is pleased to announce its new collaboration with Artemis Care Inc., a New Jersey-based remote care technology company. OneWell's innovative service offering, SmartCare by OneWell, and Artemis Care...



News published on 28 july 2022 at 18:36 and distributed by: